These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 154243)

  • 1. [Cardiovascular effects of lorcainid, a new anti-arrhythmic substance].
    Kersting F; Kasper W; Meinertz T; Just H; Jähnchen E
    Verh Dtsch Ges Inn Med; 1978; (84):687-9. PubMed ID: 154243
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic effects of intravenous pirmenol.
    Morris KG; Phillips HR
    Angiology; 1988 Mar; 39(3 Pt 2):321-6. PubMed ID: 3354931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lorcainide. I. Saturable presystemic elimination.
    Jähnchen E; Bechtold H; Kasper W; Kersting F; Just H; Heykants J; Meinertz T
    Clin Pharmacol Ther; 1979 Aug; 26(2):187-95. PubMed ID: 455887
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lorcainid--electrophysiologic examinations of a new anti-arrhythmia agent].
    Gstöttner M; Ng CK; Gmeiner R
    Acta Med Austriaca; 1978; 5(4-5):137-8. PubMed ID: 756123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacodynamics and pharmacokinetics of loracainide, a new anti-arrhythmia agent].
    Meinertz T; Kasper W; Kersting F; Just H; Jähnchen E
    Verh Dtsch Ges Inn Med; 1978; (84):1477-9. PubMed ID: 84447
    [No Abstract]   [Full Text] [Related]  

  • 6. Flecainide--a new antiarrhythmic drug.
    Drug Ther Bull; 1984 Dec; 22(25):97-8. PubMed ID: 6510231
    [No Abstract]   [Full Text] [Related]  

  • 7. Lorcainide. II. Plasma concentration-effect relationship.
    Meinertz T; Kasper W; Kersting F; Just H; Bechtold H; Jähnchen E
    Clin Pharmacol Ther; 1979 Aug; 26(2):196-204. PubMed ID: 455888
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic studies: their role in determining therapeutic efficacy of agents designed to prevent sudden death.
    Shand DG; Pritchett EL; Hammill SC; Stargel WW; Wagner GS
    Ann N Y Acad Sci; 1982; 382():238-46. PubMed ID: 7044243
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-arrhythmic action of perhexiline maleate in chronic coronary insufficiency].
    Albanese MC; Feruglio GA
    Boll Soc Ital Cardiol; 1977; 22(9):1702-7. PubMed ID: 753352
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of verapamil in coronary insufficiency and cardiac arrhythmia].
    Bobkova VI; Solomonova LN; Majorov JM; Karpickij VS; Mazurova SV
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1285+. PubMed ID: 4098327
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
    Meinertz T; Kasper W; Stengel E; Waldecker B; Löllgen H; Jähnchen E; Bechtold H; Just J
    Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new beta-receptor blockader as anti-arrhythmic agent].
    Dahlberg A
    Lakartidningen; 1972 Mar; 69(12):1334-5. PubMed ID: 4402107
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental anti-arrhythmic action of perhexiline].
    Sánchez-Pérez S; Pastelín G; Valenzuela F; Méndez R
    Arch Inst Cardiol Mex; 1976; 46(6):696-706. PubMed ID: 799493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-arrhythmic activity of quaternary derivatives of trimecaine in experimental ventricular arrhythmias].
    Gendenshteĭn EI; Tsybusov AP; Zhukauskaĭte LN; Stankevichius AP
    Biull Eksp Biol Med; 1982 Nov; 94(11):55-7. PubMed ID: 7150740
    [No Abstract]   [Full Text] [Related]  

  • 16. Electric cardioversion in treatment of atrial fibrillation.
    Zera E; Rydlewska-Sadowska W
    Pol Med J; 1969; 8(1):8-13. PubMed ID: 4238537
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation and use of the coronary and anti-arrhythmic drug Lidoflazin. Clinical, electrocardiographic, hemodynamic, and laboratory-chemical studies on 187 patients].
    Lehmann HU; Ghabussi P; Hochrein H
    Med Welt; 1977 Feb; 28(8):386-90. PubMed ID: 321914
    [No Abstract]   [Full Text] [Related]  

  • 18. Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease.
    Stewart RA; Raffel OC; Kerr AJ; Gabriel R; Zeng I; Young AA; Cowan BR
    Circulation; 2008 Sep; 118(10):1041-6. PubMed ID: 18725484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [1st experiences with the clinical use of a new antiarrhythmic agent: bunaftide].
    Lotto A; Lomanto B; Bossi M
    Cardiol Prat; 1972; 23(2):123-33. PubMed ID: 5073277
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-anginal and anti-arrhythmic properties of amiodarone].
    Rizzon P; Biasco G; Di Biase M; Antonelli G
    Boll Soc Ital Cardiol; 1972; 17(7):413-7. PubMed ID: 4650836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.